KB103

KB103 · Krystal Biotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KB103, covering 2023-01-31 to 2023-01-31. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients [Phase 1, Phase 2]